Anksiyete ve Travmatik Stres Bozuklukları

Özet

-

Referanslar

Advisory Committee FDA. SEROQUEL XR for the Treatment of Patients with either Major Depressive Disorder or Generalized Anxiety Disorder. Available at www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/

Ahrens S, Wu MV, Furlan A, Hwang GR, Paik R, Li H, Penzo MA, Tollkuhn J, Li B. A Central Extended Amygdala Circuit That Modulates Anxiety. J Neurosci. 2018 Jun 13; 38(24):5567-5583.

Alisch RS, Van Hulle C, Chopra P, Bhattacharyya A, Zhang SC, Davidson RJ, Kalin NH, Goldsmith HH. A multi-dimensional characterization of anxiety in monozygotic twin pairs reveals susceptibility loci in humans. Transl Psychiatry. 2017 Dec 11;7(12):1282.

Allgulander C, Paroxetine in social anxiety disorder: a randomized placebo-controlled study. Acta Psychiatr Scand. 1999 Sep. 100(3):193-8.

Argyropoulos SV, Bell CJ, Nutt DJ (2001) Brain function in social anxiety disorder. Psychiatr Clin North Am 24: 707–722.

Ayala ES, Meuret AE, Ritz T. Treatments for blood-injury-injection phobia: a critical review of current evidence. J Psychiatr Res. 2009 Oct. 43(15):1235-42.

Bachem R, et al. Adjustment disorder: A diagnosis whose time has come. Journal of Affective Disorders. 2018; Doi:10.1016/j.jad.2017.10.034.

Bachem R, et al. Adjustment disorder: A diagnosis whose time has come. Journal of Affective Disorders. 2018; Doi:10.1016/j.jad.2017.10.034.

Barclay TH, Barclay RD. A clinical trial of cranial electrotherapy stimulation for anxiety and comorbid depression. J Affect Disord. 2014 Aug. 164:171-7.

Bateson M, Brilot B, Nettle D.Anxiety: An evolutionary approach.Can J Psych.2011 Dec; 56(12):707-15.

Battaglia M. Separation anxiety: at the neurobiological crossroads of adaptation and illness. Dialogues Clin Neurosci. 2015 Sep;17 (3):277-85.

Bell C, Bhika S, Porter R, et al. (2008) The response to sulpiride in major depression before and after cognitive behavioural therapy: D2 receptor function. Acta Neuropsychiatr 20: 199–206.

Bourne, E. (2014). Help for anxiety. Retrieved from http://www.helpforanxiety.com/dsm-iv-tr.html

Brooks M. Adjunctive CBT First Choice for Refractory OCD. Medscape Medical News. Sep 11 2013.

Brooks M. FDA OKs Brain Stimulator for Insomnia, Anxiety, Depression. Medscape Medical News. Available at https://www.medscape.com/viewarticle/910999. March 27, 2019; Accessed: March 28, 2019.

Brooks M. FDA OKs Brain Stimulator for Insomnia, Anxiety, Depression. Medscape Medical News. Available at https://www.medscape.com/viewarticle/910999. March 27, 2019; Accessed: March 28, 2019.

Carey G, Gottesman I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Klein DF, Rabkin JG. Anxiety: New Research and Changing Concepts. New York: Raven Press; 2000.

Cha C, Nock M. Emotional intelligence is a protective factor for suicidal behavior. J Am Acad Child Adolesc Psychiatry. 2009 Apr. 48(4):422-30.

Condren RM, Sharifi N, Thakore JH (2002) A preliminary study of dopamine-mediated prolactin inhibition in generalised social phobia. Psychiatry Res 111: 87–92.

Croom KF, Perry CM, Plosker GL. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs. 2009. 23(5):427-52.

Croom KF, Perry CM, Plosker GL. Mirtazapine: a review of its use in major depression and other psychiatric disorders. CNS Drugs. 2009. 23(5):427-52.

Cuijpers P, Donker T, Weissman MM, Ravitz P, Cristea IA. Interpersonal Psychotherapy for Mental Health Problems: A Comprehensive Meta-Analysis. Am J Psychiatry. 2016 Apr 1.

Dannon PN, Lowengrub K, Amiaz R, Grunhaus L, Kotler M. Comorbid cannabis use and panic disorder: short term and long term follow-up study. Hum Psychopharmacol. 2004 Mar. 19(2):97-101

De Ross RL, Gullone E, Chorpita BF. The revised child anxiety and depression scale: a psychometric investigation with Australian Youth. Behav Change 2002;19: 90–101

Freitas-Ferrari MC, Hallak JE, Trzesniak C, Filho AS, Machado-de-Sousa JP, Chagas MH. Neuroimaging in social anxiety disorder: a systematic review of the literature. Prog Neuropsychopharmacol Biol Psychiatry. 2010 May 30. 34(4):565-80.

Gagarina, A.K. (2011). Anxiety disorder due to a general medical condition. Retrieved from http://www.health.am/psy/more/anxiety_disorder_due_to_a_general_medical_condition/

Ghasemi M, Navidhamidi M, Rezaei F, Azizikia A, Mehranfard N. Anxiety and hippocampal neuronal activity: Relationship and potential mechanisms. Cogn Affect Behav Neurosci. 2022 Jun;22(3):431-449.

Gordon JA, Hen R. The serotonergic system and anxiety. Neuromolecular Med. 2004;5 (1):27-40.

Greenberg BD, Malone DA, Friehs GM, Rezai AR, Kubu CS, Malloy PF, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 2006 Nov. 31(11):2384-93.

Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, Holt CS, Welkowitz LA, et al. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome. Arch Gen Psychiatry. 1998 Dec. 55(12):1133-41.

Herrera-Arellano A, Jiménez-Ferrer E, Zamilpa A, Morales-Valdéz M, García-Valencia CE, Tortoriello J. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam. Planta Med. 2007 Jul. 73(8):713-7.

Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001 Oct. 158(10):1568-78

Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological terapies for generalised anxiety disorder. Cochrane Database Syst Rev. 2007. (1):CD001848.

In-Albon T, Meyer AH, Schneider S. Separation anxiety avoidance inventory-child and parent version: psychometric properties and clinical utility in a clinical and school sample. Child Psychiatry Hum Dev. 2013 Dec;44(6):689-97.

Internationale Klassifikation psychischer Störungen : ICD-10, Kapitel V (‎F, klinisch-diagnostische Leitlinien / hrsg. von H. Dilling, W. Mombour und M. H. Schmid, Verlag Hans Huber, 3.Auflage

Ipser JC, Carey P, Dhansay Y, Fakier N, Seedat S, Stein DJ. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev. 2006 Oct 18.

Kendler KS, Karkowski LM, Prescott CA. Fears and phobias: reliability and heritability. Psychol Med. 1999 May. 29(3):539-53.

Kenwood MM, Kalin NH, Barbas H. The prefrontal cortex, pathological anxiety, and anxiety disorders. Neuropsychopharmacology. 2022 Jan;47(1):260-275.

Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H -U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012 Sep;21 (3):169-84.

Kim JE, Yoon SJ, Kim J, Jung JY, Jeong HS, Cho HB, et al. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial. Int J Clin Pract. 2011 Mar. 65(3):323-9.

Kluge M, Schüssler P, Steiger A. Persistent generalized anxiety after brief exposure to the dopamine antagonis metoclopramide. Psychiatry Clin Neurosci. 2007 Apr. 61(2):193-5.

Kosters ¨ MP, Chinapaw MJM, Zwaanswijk M, van der Wal MF, Koot HM. Structure, reliability, and validity of the revised child anxiety and depression scale (RCADS) in a multi-ethnic urban sample of Dutch children. BMC Psychiatry 2015;15:132.

Lewis C, Pearce J, Bisson JI. Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review. Br J Psychiatry. 2012 Jan. 200:15-21.

Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, Pine DS. Classical fear conditioning in the anxiety disorders: a meta-analysis. Behav Res Ther. 2005 Nov;43(11):1391-424

Lochner C, Mogotsi M, Toit PL, Kaminer D, Niehaus D J, Stein DJ, Quality of Life in Anxiety Disorders: A Comparison of Obsessive-CompulsiveDisorder, Social Anxiety Disorder, and Panic Disorder, Psychopathology 2003;36:255–262

Logue MW, Bauver SR, Knowles JA, et al. Multivariate analysis of anxiety disorders yields further evidence of linkage to chromosomes 4q21 and 7p in panic disorder families. Am J Med Genet B Neuropsychiatr Genet. 2012 Apr. 159B(3):274-80

Lydiard RB. The role of drug therapy in social phobia. J Affect Disord. 1998 Sep. 50 Suppl 1:S35-9.

Mackintosh MA, Gatz M, Wetherell JL, Pedersen NL. A twin study of lifetime Generalized Anxiety Disorder (GAD) in older adults: genetic and environmental influences shared by neuroticism and GAD. Twin Res Hum Genet. 2006 Feb;9(1):30-7.

Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996 Feb. 53(2):159-68.

Martinez RC, Ribeiro de Oliveira A, Brandão ML. Serotonergic mechanisms in the basolateral amygdala differentially regulate the conditioned and unconditioned fear organized in the periaqueductal gray. Eur Neuropsychopharmacol. 2007 Nov. 17(11):717-24.

Martinez RC, Ribeiro de Oliveira A, Brandão ML. Serotonergic mechanisms in the basolateral amygdala differentially regulate the conditioned and unconditioned fear organized in the periaqueductal gray. Eur Neuropsychopharmacol. 2007 Nov. 17(11):717-24.

Mathew SJ, Coplan JD, Gorman JM (2001) Neurobiological mechanisms of social anxiety disorder. Am J Psychiatry 158: 1558–1567.

Mayor S. NICE advocates computerised CBT. BMJ. 2006 Mar 4. 332(7540):504.119

Mikkelsen EJ, Detlor J, Cohen DJ (1981) School avoidance and social phobia triggered by haloperidol in patients with Tourette’s disorder. Am J Psychiatry 138: 1572– 1576

Mochcovitch MD, da Rocha Freire RC, Garcia RF, Nardi AE. A systematic review of fMRI studies in generalized anxiety disorder: evaluating its neural and cognitive basis. J Affect Disord. 2014;167:336

Muris P, Simon E, Lijphart H, Bos A, Hale W, Schmeitz K., International Child and Adolescent Anxiety Assessment Expert Group (ICAAAEG). The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents. Child Psychiatry Hum Dev. 2017 Feb;48(1):1-17.

Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA. Reduced serotonin type A receptor binding in panic disorder. J Neurosci. 2004 Jan 21. 24(3):589-91.

Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ. Anticipatory activation. In the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry. 2009 Mar. 166(3):302-10.

Nitschke JB, Sarinopoulos I, Oathes DJ, Johnstone T, Whalen PJ, Davidson RJ. Anticipatory activation. In the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry. 2009 Mar. 166(3):302-10.

Pallanti S, Quercioli L, Rossi A, et al. (1999) The emergence of social phobia during clozapine treatment and its response to fluoxetine augmentation. J Clin Psychiatry 60: 819–823.

Ramsawh HJ, Chavira DA, Stein MB. Burden of anxiety disorders in pediatric medical settings: prevalence, phenomenology, and a research agenda. Arch Pediatr Adolesc Med. 2010 Oct; 164(10):965-72.

Rothbaum BO, Anderson P, Zimand E, Hodges L, Lang D, Wilson J. Virtual reality exposure therapy and standard (in vivo) exposure therapy in the treatment of fear of flying. Behav Ther. 2006 Mar. 37(1):80-90.

Sareen J, Campbell DW, Leslie WD, et al. (2007) Striatal function in generalized social phobia: a functional magnetic resonance imaging study. Biol Psychiatry 61: 396–404.

Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry. 2005 Nov. 62(11):1249-57.

Sbicigo JB, Toazza R, Becker N, Ecker K, Manfro GG, Salles JF. Memory and language impairments are associated with anxiety disorder severity in childhood. Trends Psychiatry Psychother. 2020 Jun;42(2):161-170.

Schneier FR, Heckelman LR, Garfinkel R, Campeas R, Fallon BA, Gitow A. Functional impairment in social phobia. J Clin Psychiatry. 1994 Aug. 55(8):322-31.

Schneier FR, Liebowitz MR, Abi-Dargham A, et al. (2000) Low dopamine D(2) receptor binding potential in social phobia. Am J Psychiatry 157: 457–459.

Shear MK, Beidel DC. Psychotherapy in the overall management strategy for social anxiety disorder. J Clin Psychiatry. 1998. 59 Suppl 17:39-46.

Siegmann E-M, Müller H, Luecke C, et al. Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. JAMA. May 2, 2018.

Simon E, Bögels SM. Screening for anxiety disorders in children. Eur Child Adolesc Psychiatry. 2009 Oct;18(10):625-34.

Sinclair LI, Christmas DM, Hood SD, Potokar JP, Robertson A, Isaac A. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry. 2009 Jun. 194(6):483-90.

Sood, E.D., Mendez, J.L., & Kendall, P.C. (2012). Acculturation, religiosity, and ethnicity predict mother’s causal beliefs about separation anxiety disorder and preferences for help seeking. Journal of Cross-Cultural Psychology, 43(3) 393-409

Stein MB, Fyer AJ, Davidson JR, Pollack MH, Wiita B. Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study. Am J Psychiatry. 1999 May. 156(5):756-60.

Stein MB, Stein DJ. Social anxiety disorder. Lancet. 2008 Mar 29. 371(9618):1115-25.

Tambs K, Czajkowsky N, Røysamb E, Neale MC, Reichborn-Kjennerud T, Aggen SH. Structure of genetic and environmental risk factors for dimensional representations of DSM-IV anxiety disorders. Br J Psychiatry. 2009 Oct. 195(4):301-7.

Tancer ME, Mailman RB, Stein MB, et al. (1994) Neuro-endocrine responsivity to monoaminergic system probes in generalized social phobia. Anxiety 1: 216–223.

The lifeline and Suicide & Crisis Lifeline. https://988lifeline.org/current-events/the-lifeline-and-988/. Accessed March 16, 2023.

The lifeline and Suicide & Crisis Lifeline. https://988lifeline.org/current-events/the-lifeline-and-988/. Accessed March 16, 2023.

The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1061-9.

The Research Units On Pediatric P. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002;41:1061–9

Tiihonen J, Kuikka J, Bergstrom K, et al. (1997) Dopamine reuptake site densities in patients with social phobia. Am J Psychiatry 154: 239-242

Toneatto T, Nguyen L. Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Can J Psychiatry. 2007 Apr. 52(4):260-6.

Tükel R, Alkın T. (ed.) Anksiyete Bozuklukları. Ankara; Türkiye Psikiyatri Derneği Yayınları, 2006.

Uhlenhuth EH, Balter MB, Ban TA, Yang K. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. Depress Anxiety. 1999. 9(3):107-16.

Van Ameringen M, Allgulander C, Bandelow B, Greist JH, Hollander E, Montgomery SA, et al. WCA recommendations for the long-term treatment of social phobia. CNS Spectr.2003 Aug.8 (8 Suppl1):40-52.

Vaughan J, Coddington JA, Ahmed AH, Ertel M. Separation Anxiety Disorder in School-Age Children: What Health Care Providers Should Know. J Pediatr Health Care. 2017 Jul-Aug; 31(4):433-440.

Voltas N, Hernández-Martínez C, Arija V, Canals J. The natural course of anxiety symptoms in early adolescence: factors related to persistence. Anxiety Stress Coping. 2017 Nov;30 (6):671-686.

Vythilingam M, Anderson ER, Goddard A, Woods SW, Staib LH, Charney DS. Temporal lobe volume in panic disorder--a quantitative magnetic resonance imaging study. Psychiatry Res. 2000 Aug 28. 99(2):75-82.

Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, et al. Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol. 2002 Fall. 12(3):175-88.

Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25;359 (26):2753-66.

Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, Ripperger-Suhler J, Rockhill C. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-1124.

Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017 Nov 01;171 (11):1049-1056.

Watson D, Friend R (1969) Measurement of social-evaluative anxiety. J Consult Clin Psychol 33: 448–457.

Weisberg RB. Overview of generalized anxiety disorder: epidemiology, presentation, and course. J Clin Psychiatry. 2009;70 Suppl 2:4-9.

Williams K, Argyropoulos S, Nutt DJ (2000) Amphetamine misuse and social phobia. Am J Psychiatry 157: 834–835.

Wittchen HU, Fehm L. Epidemiology, patterns of comorbidity, and associated disabilities of social phobia. Psychiatr Clin North Am. 2001 Dec. 24(4):617-41

Womersley K, Ripullone K, Agius M. What are the risks associated with different Selective Serotonin Re-uptake Inhibitors (SSRIs) to treat depression and anxiety in pregnancy? An evaluation of current evidence. Psychiatr Danub. 2017;29(Suppl 3):629–44.

Zarrindast MR, Khakpai F. The Modulatory Role of Dopamine in Anxiety-like Behaviour. Arch Iran Med. 2015 Sep;18(9):591-603

American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. APA Publishing, Arlington, VA.

Astrid R. S, Thomas J, Lars W, Stian L, Nanna S. K, 13 November 2020. Reactive attachment disorder and disinhibited social engagement disorder in adolescence: co‑occurring psychopathology and psychosocial problems. European Child & Adolescent Psychiatry (2022) 31:85–98

Battaglia M. Separation anxiety: at the neurobiological crossroads of adaptation and illness. Dialogues Clin Neurosci. 2015 Sep;17 (3):277-85.

Behrens B, Swetlitz C, Pine DS, Pagliaccio D. The Screen for Child Anxiety Related Emotional Disorders (SCARED): Informant Discrepancy, Measurement In variance, and Test-Retest Reliability. Child Psychiatry Hum Dev. 2019 Jun;50(3):473-482.

Behrens B, Swetlitz C, Pine DS, Pagliaccio D. The Screen for Child Anxiety Related Emotional Disorders (SCARED): Informant Discrepancy, Measurement In variance, and Test-Retest Reliability. Child Psychiatry Hum Dev. 2019 Jun;50(3):473-482.

Bittner A, Egger HL, Erkanli A, Jane Costello E, Foley DL, Angold A. What do childhood anxiety disorders predict? J Child Psychol Psychiatry. 2007 Dec;48(12):1174-83.

Braun K, Bock J. The experience-dependent maturation of prefronto-limbic circuits and the origin of developmental psychopathology: implications for the pathogenesis and therapy of behavioural disorders. Dev Med Child Neurol. 2011 Sep;53 Suppl 4:14-8.

Building your resilience. American Psychological Association. https://www.apa.org/topics/resilience/building-your-resilience. Accessed March 17, 2023

Carey G, Gottesman I. Twin and family studies of anxiety, phobic, and obsessive disorders. In: Klein DF, Rabkin JG. Anxiety: New Research and Changing Concepts. New York: Raven Press; 2000.

de Ross RL, Gullone E, Chorpita BF. The revised child anxiety and depression scale: a psychometric investigation with australian youth. Behav Change 2002;19: 90–101

De Ross RL, Gullone E, Chorpita BF. The revised child anxiety and depression scale: a psychometric investigation with australian youth. Behav Change 2002;19: 90–101

Dickie EW, Brunet A, Akerib V, Armony JL. An fMRI investigation of memory encoding in PTSD: influence of symptom severity. Neuropsychologia. 2008 Apr. 46(5):1522-31.

Ezpeleta L, Keeler G, Erkanli A, Costello EJ, Angold A. Epidemiology of psychiatric disability in childhood and adolescence. J Child Psychol Psychiatry. 2001 Oct;42(7):901-14.

Geer K. Adjustment disorder: Diagnosis and treatment in primary care. In: Primary Care: Clinics in Office Practice. Volume 50, issue 1. Elsevier; 2023. https://www.clinicalkey.com/. Accessed March 17, 2023.

Germain A, Shear MK, Hall M, Buysse DJ. Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study. Behav Res Ther. 2007 Mar. 45(3):627-32.

Ginsburg GS, Becker-Haimes EM, Keeton C, Kendall PC, Iyengar S, Sakolsky D, Albano AM, Peris T, Compton SN, Piacentini J. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes. J Am Acad Child Adolesc Psychiatry. 2018 Jul;57 (7):471-480.

Havinga PJ, Boschloo L, Bloemen AJ, Nauta MH, de Vries SO, Penninx BW, Schoevers RA, Hartman CA. Doomed for Disorder? High Incidence of Mood and Anxiety Disorders in Offspring of Depressed and Anxious Patients: A Prospective Cohort Study. J Clin Psychiatry. 2017 Jan;78 (1):e8-e17.

Högberg G, Pagani M, Sundin O, Soares J, Aberg-Wistedt A, Tärnell B. Treatment of post-traumatic stress disorder with eye movement desensitization and reprocessing: outcome is stable in 35-month follow-up. Psychiatry Res. 2008 May 30. 159(1-2):101-8.

Internationale Klassifikation psychischer Störungen : ICD-10, Kapitel V (‎F, klinisch-diagnostische Leitlinien / hrsg. von H. Dilling, W. Mombour und M. H. Schmid, Verlag Hans Huber, 3.Auflage

Karaytuğ MO, Tamam L, Demirkol ME, Namlı Z, Gürbüz M, Yeşiloğlu C. Impact of Childhood Trauma and Adult Separation Anxiety Disorder on Quality of Life in Individuals with Schizophrenia. Neuropsychiatr Dis Treat. 2023; 19:181-196.

Keeton CP, Kolos AC, Walkup JT. Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management. Paediatr Drugs. 2009. 11(3):171-83

Kind MA, Peskind ER, Hoff DJ, Hart KL, Holmes HA, Warren D. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007 Apr 15. 61(8):928-34.

Lebowitz ER, Leckman JF, Silverman WK, Feldman R. Cross-generational influences on childhood anxiety disorders: pathways and mechanisms. J Neural Transm (Vienna). 2016 Sep;123(9):1053-67

Lionetti F, Pastore M, Barone L. Attachment in institutionalized children: a review and meta-analysis. Child Abuse Negl. 2015 Apr;42:135-45.

Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an Internet-based, terapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. 2007 Nov. 164(11):1676-83.

Manicavasagar V, Marnane C, Pini S, Abelli M, Rees S,Eapen V, Silove D. Adult separation anxiety disorder: a disorder comes of age. Curr Psychiatry Rep. 2010 Aug; 12 (4):290-7.

Marshall RD, Pierce D. Implications of recent findings in posttraumatic stress disorder and the role of pharmacotherapy. Harv Rev Psychiatry. 2000 Jan-Feb. 7(5):247-56.

Masi G, Mucci M, Millepiedi S. Separation anxiety disorder in children and adolescents: epidemiology, diagnosis and management. CNS Drugs. 2001; 15(2):93-104.

Milad MR, Orr SP, Lasko NB, Chang Y, Rauch SL, Pitman RK. Presence and acquired origin of reduced recall for fear extinction in PTSD: results of a twin study. J Psychiatr Res. 2008 Jun. 42(7):515-20.

Milot T, Ethier LS, St-Laurent D, Provost MA. The role of trauma symptoms in the development of behavioral problems in maltreated preschoolers. Child Abuse Negl. 2010 Apr;34(4):225-34.

Moran K, McDonald J, Jackson A, Turnbull S, Minnis H. A study of Attachment Disorders in young offenders attending specialist services. Child Abuse Negl. 2017 Mar;65:77-87.

Muris P, Simon E, Lijphart H, Bos A, Hale W, Schmeitz K., International Child and Adolescent Anxiety Assessment Expert Group (ICAAAEG). The Youth Anxiety Measure for DSM-5 (YAM-5): Development and First Psychometric Evidence of a New Scale for Assessing Anxiety Disorders Symptoms of Children and Adolescents. Child Psychiatry Hum Dev. 2017 Feb;48(1):1-17.

O'Donnell ML, et al. Adjustment disorder: Current developments and future directions. International Journal of Environmental Research and Public Health. 2019; Doi: 10.3390/ijerph16142537.

Patel AK, Bryant B. Separation Anxiety Disorder. JAMA. 2021 Nov 09; 326 (18):1880.

Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1061-9.

Ponniah K, Hollon SD. Empirically supported psychological treatments for adult acute stress disorder and posttraumatic stress disorder: a review. Depress Anxiety. 2009. 26(12):1086-109.

Pritchett R, Pritchett J, Marshall E, Davidson C, Minnis H. Reactive attachment disorder in the general population: a hidden ESSENCE disorder. ScientificWorldJournal. 2013;2013:818157.

Pritchett R, Pritchett J, Marshall E, Davidson C, Minnis H. Reactive attachment disorder in the general population: a hidden ESSENCE disorder. ScientificWorldJournal. 2013;2013:818157.

Rappaport BI, Pagliaccio D, Pine DS, Klein DN, Jarcho JM. Discriminant validity, diagnostic utility, and parent-child agreement on the Screen for Child Anxiety Related Emotional Disorders (SCARED) in treatment- and non-treatment-seeking youth. J Anxiety Disord. 2017 Oct;51:22-31.

Rodriguez BF, Weisberg RB, Pagano ME, Machan JT, Culpepper L, Keller MB. Mental health treatment received by primary care patients with posttraumatic stress disorder. JClin Psychiatry.2003 Oct. 64(10):1230-6.

Sbicigo JB, Toazza R, Becker N, Ecker K, Manfro GG, Salles JF. Memory and language impairments are associated with anxiety disorder severity in childhood. Trends Psychiatry Psychother. 2020 Jun;42(2):161-170.

Seim AR, Wichstrøm LT, Lydersen S, Kayed NS, Reactive attachment disorder and disinhibited social engagement disorder in adolescence: co‑occurring psychopathology and psychosocial problems. European Child & Adolescent Psychiatry 2022, 31:85–98, https://doi.org/10.1007/s00787-020-01673-7

Shipman K, Taussig H. Mental health treatment of child abuse Lebowitz ER, Leckman JF, Silverman WK, Feldman R. Cross-generational influences on childhood anxiety disorders: pathways and mechanisms. J Neural Transm (Vienna). 2016 Sep;123(9):1053-67

Shipon-Blum E, Selective Mutism – A Comprehensive Overview, SMartCenter@SelectiveMutismCenter.org

Simon E, Bögels SM. Screening for anxiety disorders in children. Eur Child Adolesc Psychiatry. 2009 Oct;18(10):625-34.

Spratt EG, Friedenberg SL, Swenson CC, Larosa A, De Bellis MD, Macias MM, Summer AP, Hulsey TC, Runyan DK, BTBBy KT. The Effects of Early Neglect on Cognitive, Language, and Behavioral Functioning in Childhood. Psychology. 2012 Feb 01;3(2):175-182.

Spratt EG, Friedenberg SL, Swenson CC, Larosa A, De Bellis MD, Macias MM, Summer AP, Hulsey TC, Runyan DK, BTBBy KT. The Effects of Early Neglect on Cognitive, Language, and Behavioral Functioning in Childhood. Psychology. 2012 Feb 01;3(2):175-182.

The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1061-9.

The Research Units On Pediatric P. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002;41:1061–9

Toneatto T, Nguyen L. Does mindfulness meditation improve anxiety and mood symptoms? A review of the controlled research. Can J Psychiatry. 2007 Apr. 52(4):260-6.

Voltas N, Hernández-Martínez C, Arija V, Canals J. The natural course of anxiety symptoms in early adolescence: factors related to persistence. Anxiety Stress Coping. 2017 Nov;30 (6):671-686.

Walkup J, Labellarte M, Riddle MA, Pine DS, Greenhill L, Fairbanks J, et al. Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study. J Child Adolesc Psychopharmacol. 2002 Fall. 12(3):175-88.

Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT, Ginsburg GS, Rynn MA, McCracken J, Waslick B, Iyengar S, March JS, Kendall PC. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25;359 (26):2753-66.

Walter HJ, Bukstein OG, Abright AR, Keable H, Ramtekkar U, Ripperger-Suhler J, Rockhill C. Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-1124.

Wang Z, Whiteside SPH, Sim L, Farah W, Morrow AS, Alsawas M, Barrionuevo P, Tello M, Asi N, Beuschel B, Daraz L, Almasri J, Zaiem F, Larrea-Mantilla L, Ponce OJ, LeBlanc A, Prokop LJ, Murad MH. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis. JAMA Pediatr. 2017 Nov 01;171 (11):1049-1056.

Winston R, Chicot R. The importance of early bonding on the long-term mental health and resilience of children. London J Prim Care (Abingdon). 2016;8(1):12-14.

Zeanah CH, Chesher T, Boris NW. American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice Parameter for the Assessment and Treatment of Children and Adolescents With Reactive Attachment Disorder and Disinhibited Social Engagement Disorder. J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):990-1003

Zeanah CH, Chesher T, Boris NW. American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI). Practice Parameter for the Assessment and Treatment of Children and Adolescents With Reactive Attachment Disorder and Disinhibited Social Engagement Disorder. J Am Acad Child Adolesc Psychiatry. 2016 Nov;55(11):990-1003.

Abramowitz JS, Wheaton MG, Storch EA (September 2008). "The status of hoarding as a symptom of obsessive-compulsive disorder". Behaviour Research and Therapy. 46 (9): 1026–1033. Doi:10.1016/j.brat.2008.05.006.

American Psychiatric Association Work Group on Obsessive-Compulsive Disorder. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. July 2007. 164(suppl):1-56.

American Psychiatric Association Work Group on Obsessive-Compulsive Disorder. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. July 2007. 164(suppl):1-56.

American Psychiatric Association, 2013. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition. APA Publishing, Arlington, VA.

Andrade C. Ondansetron augmentation of serotonin reuptake inhibitors as a treatment strategy in obsessive-compulsive disorder. J Clin Psychiatry. 2015 Jan. 76 (1):e72-5

Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obessive-compulsive disorder: a preliminary study. Psychopharmacology. August 2004. 174:530-538.

Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006 Jul. 63(7):769-76.

Ayers CR, Saxena S, Golshan S, Wetherell JL (February 2010). "Age at onset and clinical features of late life compulsive hoarding". International Journal of Geriatric Psychiatry. 25 (2): 142–149. Doi:10.1002/gps.2310.

Barlow JH, Ellard DR, Hainsworth JM, Jones FR, Fisher A. A review of self-management interventions for panic disorders, phobias and obsessive-compulsive disorders. Acta Psychiatr Scand. 2005 Apr. 111(4):272-85.

Bartz, J.A. and Hollander, E. (2006) Is Obsessive-Compulsive Disorder an Anxiety Disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 338-352.

Bartz, J.A. and Hollander, E. (2006) Is Obsessive-Compulsive Disorder an Anxiety Disorder? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30, 338-352.

Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan. 42(1):1-13.

Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan. 42(1):1-13.

Bienvenu OJ, Samuels JF, Wuyek LA, Liang KY, Wang Y, Grados MA, et al. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012 Jan. 42(1):1-13.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry. 2006 Jul. 11(7):622-32.

Borue X, Sharma M, Hudak R. Biological treatments for obsessive-compulsive and related disorders. J Obsessive Compuls Relat Disord. 2015;6:7–26.

Bulut S D, Özdel K, Kısa C, Belirtiden Bozukluğa İstifleme. Hoarding, Psikiyatride Güncel Yaklaşımlar- Current Approaches in Psychiatry 2015;7(3):319-332 doi:10.5455/cap.20141220023913

Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, et al. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry. 2005 Sep1.58(5):424-8.

Cromer KR, Schmidt NB, Murphy DL (November 2007). "Do traumatic events influence the clinical expression of compulsive hoarding?". Behaviour Research and Therapy. 45 (11): 2581–2592. Doi:10.1016/j.brat.2007.06.005.

Crone C, Norberg MM (August 2018). "Scared and surrounded by clutter: The influence of emotional reactivity". Journal of Affective Disorders. 235: 285–292.

Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebocontrolled trials. Int J Neuropsychopharmacol. 2013;16(3):557–74.

Eryılmaz G, Erkmen H, Gül I G., Transcranial Direct Current Stimulation. Anatolian Journal of Psychiatry. 2015; 16:138-142.

Ferrão AY, Diniz JB, Lopes AC, Shavitt RG, Greenberg B, Miguel E, Resistance and refractoriness in obsessive-compulsive disorder, Braz. J. Psychiatry 29 (suppl 2), Oct 2007 https://Doi.org/10.1590/S1516-44462006005000059

Foa EB, Wilson R. Stop Obsessing: How to Overcome Your Obsessions and Compulsions. Revis ed. New York: Bantam Dell; 2001

Fontenelle LF, Muhlbauer JE, Albertella L, Eppingstall J (2021-01-01). "Traumatic and stressful life events in hoarding: the role of loss and deprivation". European Journal of Psychotraumatology. 12 (1): 1947002. Doi:10.1080/20008198.2021.1947002.

Fontenelle, Leonardo F.; Grant, Jon E. (2014). "Hoarding disorder: a new diagnostic category in ICD-11?". Revista Brasileira de Psiquiatria (Sao Paulo, Brazil: 1999). 36 (Suppl 1): 28–39. Doi:10.1590/1516-4446-2013-1269.

Frost RO, Steketee G, Tolin DF (October 2011). "Comorbidity in hoarding disorder". Depression and Anxiety. 28 (10): 876–884.

Ghaleiha A, Entezari N, Modabbernia A, Najand B, Askari N, Tabrizi M, et al. Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study. J Psychiatr Res. 2013 Feb. 47(2):175-80.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov. 46(11):1006-11.

Grayson J. Freedom From Obsessive Compulsive Disorder: A Personalized Recovery Program for Living With Uncertainty. New York: Berkley Publishing Group; 2004.

Greenberg WM, Benedict MM, Doerfer J, Perrin M, Panek L, Cleveland WL, et al. Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults. J Psychiatr Res. 2009 Mar. 43(6):664-70.

Grisham JR, Frost RO, Steketee G, Kim HJ, Hood S (2006). "Age of onset of compulsive hoarding". Journal of Anxiety Disorders. 20 (5): 675–86. Doi:10.1016/j.janxdis.2005.07.004.

Grisham JR, Norberg MM (2010-06-30). "Compulsive hoarding: current controversies and new directions". Dialogues in Clinical Neuroscience. 12 (2): 233–240. Doi:10.31887/DCNS.2010.12.2/jgrisham.

Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, et al. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology (Berl). 2013 Mar 23.

Internationale Klassifikation psychischer Störungen : ICD-10, Kapitel V (‎F, klinisch-diagnostische Leitlinien / hrsg. von H. Dilling, W. Mombour und M. H. Schmid, Verlag Hans Huber, 3.Auflage

Jung HH, Kim CH, Chang JH, Park YG, Chung SS, Chang JW. Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: Long-term follow-up results. Stereotact Funct Neurosurg. 2006. 84(4):184-9.

Jung HH, Kim CH, Chang JH, Park YG, Chung SS, Chang JW. Bilateral anterior cingulotomy for refractory obsessive-compulsive disorder: Long-term follow-up results. Stereotact Funct Neurosurg. 2006. 84(4):184-9.

Komossa K, Depping AM, Meyer M, Kissling W, Leucht S. Second-generation antipsychotics for obsessive compulsive disorder. Cochrane Database Syst Rev. 2010 Dec 8. 12:CD008141.

Koran LM, Aboujaoude E. Promising treatments for obsessive-compulsive disorder: a call for additional research. Curr Med Chem. 2018;25(41):5690–7.

Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry. 2007 Jul. 164(7 Suppl):5-53.

Kuwano M, Nakao T, Yonemoto K, Yamada S, Murayama K, Okada K, et al. (March 2020). "Clinical characteristics of hoarding disorder in Japanese patients". Heliyon. 6 (3): e03527. Doi:10.1016/j.heliyon.2020.e03527.

Kwok C, Grisham JR, Norberg MM (December 2018). "Object attachment: Humanness increases sentimental and instrumental values". Journal of Behavioral Addictions. 7 (4): 1132–1142. Doi:10.1556/2006.7.2018.98.

Lin PY. Meta-analysis of the association of serotonin transporter gene polymorphism with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13. 31(3):683-9.

Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008 Nov 13. 359(20):2121-34.

Marcks BA, Weisberg RB, Dyck I, Keller MB. Longitudinal course of obsessive-compulsive disorder in patients with anxiety disorders: a 15-year prospective follow-up study. Compr Psychiatry. 2011;52(6):670–7.

Marinova Z, Chuang DM, Fineberg N. Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr Neuropharmacol. 2017;15(7):977–95.

Marinova Z, Chuang DM, Fineberg N. Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr Neuropharmacol. 2017;15(7):977–95.

Norberg MM, Crone C, Kwok C, Grisham JR (March 2018). "Anxious attachment and excessive acquisition: The mediating roles of anthropomorphism and distress intolerance". Journal of Behavioral Addictions. 7 (1): 171–180. Doi:10.1556/2006.7.2018.08.

Norberg MM, Kwok C, Crone C, David J, Kakar V, Grisham JR (2020). "Greater interpersonal problems differentiate those who excessively acquire and save from those who only excessively acquire possessions". Journal of Obsessive-Compulsive and Related Disorders. 27: 100571. Doi:10.1016/j.jocrd.2020.100571.

Nordsletten, A.E., Fernández de la Cruz, L., Pertusa, A., Reichenberg, A., Hatch, S.L., Mataix-Cols, D., 2013. The Structured Interview for Hoarding Disorder (SIHD): Development, usage and further validation. Journal of Obsessive Compulsive and Related Disorders 2(3), 346-350.

Nordsletten, A.E., Fernández de la Cruz, L., Pertusa, A., Reichenberg, A., Hatch, S.L., Mataix-Cols, D., 2013. The Structured Interview for Hoarding Disorder (SIHD): Development, usage and further validation. Journal of Obsessive Compulsive and Related Disorders 2(3), 346-350.

Pepper J, Hariz M, Zrinzo L. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. J Neurosurg. 2015 May. 122 (5):1028-37.

Pertusa A, Frost RO, Fullana MA, Samuels J, Steketee G, Tolin D, et al. (June 2010). "Refining the diagnostic boundaries of compulsive hoarding: a critical review". Clinical Psychology Review. 30 (4): 371–386. Doi:10.1016/j.cpr.2010.01.007.

Pertusa A, Fullana MA, Singh S, Alonso P, Menchón JM, Mataix-Cols D (October 2008). "Compulsive hoarding: OCD symptom, distinct clinical syndrome, or both?". The American Journal of Psychiatry. 165 (10): 1289–298. Doi:10.1176/appi.ajp.2008.07111730.

Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx. 2006 Jan. 3(1):69-81

Postlethwaite, A., Kellett, S., Mataix-Cols, D., 2019. Prevalence of Hoarding Disorder: A systematic review and meta-analysis. J Affect Disord 256, 309-316.

Saxena S (May 2011). "Pharmacotherapy of compulsive hoarding". Journal of Clinical Psychology. 67 (5): 477–484. Doi:10.1002/jclp.20792.

Sayyah M, Sayyah M, Boostani H, Ghaffari SM, Hoseini A. Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder (a double blind clinical trial). Depress Anxiety. 2012;29(10):850–4

Schneier FR, Martinez D, Abi-Dargham A, et al. (2008) Striatal dopamine D(2) receptor availability in OCD with and without comorbid social anxiety disorder: preliminary findings. Depress Anxiety 25:1–7.

Simpson HB, Foa EB, Liebowitz MR, et al. Cognitive-Behavioral Therapy vs Risperidone for Augmenting Serotonin Reuptake Inhibitors in Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Sep 11 2013.

Simpson HB, Wetterneck CT, Cahill SP, Steinglass JE, Franklin ME, Leonard RC, et al. Treatment of obsessive-compulsive disorder complicated by comorbid eating disorders. Cogn Behav Ther. 2013 Mar. 42(1):64-76.

Stetka B, Correll, C. A Guide to DSM-5: Hoarding, Skin-Picking, and Rethinking OCD. Available. Medscape Medical News. Available at http://www.medscape.com/viewarticle/803884_7. Accessed: July 1, 2013.

Tolin DF, Frost RO, Steketee G (July 2007). "An open trial of cognitive-behavioural therapy for compulsive hoarding". Behaviour Research and Therapy. 45 (7): 1461–1470.

Tolin DF, Frost RO, Steketee G, Muroff J (March 2015). "Cognitive behavioural therapy for hoarding disorder: a meta-analysis". Depression and Anxiety. 32 (3): 158–166. Doi:10.1002/da.22327.

Tolin DF, Meunier SA, Frost RO, Steketee G (September 2010). "Course of compulsive hoarding and its relationship to life events". Depression and Anxiety. 27 (9): 829–38. Doi:10.1002/da.20684.

Tolin, D.F., Frost, R.O., Steketee, G., 2010. A brief interview for assessing compulsive hoarding: The Hoarding Rating Scale-Interview. Psychiatry Res 178(1), 147-152.

Van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. 2005 Oct. 8(5):450-8.

Van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. Twin studies on obsessive-compulsive Twin Res Hum Genet. 2005 Oct;8(5):450-8

Wenting C, Skye M, Travis W, Grisham J, (June 2021). "Investigating associations between hoarding symptoms and affective and cognitive empathy". The British Journal of Clinical Psychology. 60 (2): 177–193. Doi:10.1111/bjc.12280.

Wu K, Hanna GL, Rosenberg DR, Arnold PD. The role of glutamate signalling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav. 2012 Feb. 100(4):726-35.

Yayınlanan

7 Ağustos 2024

Lisans

Lisans

Bu İnternet Sitesi içeriğinde yer alan tüm eserler (yazı, resim, görüntü, fotoğraf, video, müzik vb.) Akademisyen Kitabevine ait olup, 5846 sayılı Fikir ve Sanat Eserleri Kanunu ve 5237 sayılı Türk Ceca Kanunu kapsamında korunmaktadır. Bu hakları ihlal eden kişiler, 5846 sayılı Fikir ve Sanat eserleri Kanunu ve 5237 sayılı Türk Ceza Kanununda yer alan hukuki ve cezai yaptırımlara tabi olurlar. Yayınevi ilgili yasal yollara başvurma hakkına sahiptir.

Mevcut yayın biçimiyle ilgili ayrıntılar: PDF

PDF

ISBN-13 (15)

978-625-399-950-6

Publication date (01)

2024

Fiziksel Boyutlar